Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (431-440 of 574) with videos related to

Pageof 58
Sort By:
Journal of Parkinson'S Disease|January 14, 2020
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's DiseaseCaroline M Tanner, Rajesh Pahwa, Robert A Hauser, et al.
Neuroscience Letters|August 25, 2012
Mutation screening of the HTR2B gene in patients with Tourette syndromeYi Guo, Xiong Deng, Joseph Jankovic, et al.
Parkinsonism & Related Disorders|September 24, 2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A Hauser, et al.
Surgical Neurology|June 3, 2008
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's diseaseAdriana M Strutt, Eugene C Lai, Joseph Jankovic, et al.
Movement Disorders Clinical Practice|July 17, 2018
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter StudyJoseph Jankovic, Daniel Truong, Atul T Patel, et al.
Neuroscience Letters|October 19, 2010
LINGO1 rs9652490 variant in Parkinson disease patientsYi Guo, Joseph Jankovic, Zhi Song, et al.
Parkinsonism & Related Disorders|August 22, 2020
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment toolRoongroj Bhidayasiri, John M Kane, Karen P Frei, et al.
The Lancet. Neurology|November 27, 2019
Essential tremor-plus: a controversial new conceptElan D Louis, Martin Bares, Julian Benito-Leon, et al.
Movement Disorders Clinical Practice|September 29, 2023
Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?Adam C Cotton, Laura Scorr, William McDonald, et al.
The New England Journal of Medicine|September 25, 2009
A double-blind, delayed-start trial of rasagiline in Parkinson's diseaseC Warren Olanow, Olivier Rascol, Robert Hauser, et al.
Pageof 58

Showing results (431-440 of 574) with videos related to

Sort By:
Pageof 58
Journal of Parkinson'S Disease|January 14, 2020
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's DiseaseCaroline M Tanner, Rajesh Pahwa, Robert A Hauser, et al.
Neuroscience Letters|August 25, 2012
Mutation screening of the HTR2B gene in patients with Tourette syndromeYi Guo, Xiong Deng, Joseph Jankovic, et al.
Parkinsonism & Related Disorders|September 24, 2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A Hauser, et al.
Surgical Neurology|June 3, 2008
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's diseaseAdriana M Strutt, Eugene C Lai, Joseph Jankovic, et al.
Movement Disorders Clinical Practice|July 17, 2018
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter StudyJoseph Jankovic, Daniel Truong, Atul T Patel, et al.
Neuroscience Letters|October 19, 2010
LINGO1 rs9652490 variant in Parkinson disease patientsYi Guo, Joseph Jankovic, Zhi Song, et al.
Parkinsonism & Related Disorders|August 22, 2020
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment toolRoongroj Bhidayasiri, John M Kane, Karen P Frei, et al.
The Lancet. Neurology|November 27, 2019
Essential tremor-plus: a controversial new conceptElan D Louis, Martin Bares, Julian Benito-Leon, et al.
Movement Disorders Clinical Practice|September 29, 2023
Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?Adam C Cotton, Laura Scorr, William McDonald, et al.
The New England Journal of Medicine|September 25, 2009
A double-blind, delayed-start trial of rasagiline in Parkinson's diseaseC Warren Olanow, Olivier Rascol, Robert Hauser, et al.
Pageof 58